BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9458437)

  • 21. Vasodilators in the treatment of primary pulmonary hypertension.
    Weir EK; Schremmer B
    Eur Respir J; 1998 Aug; 12(2):263-4. PubMed ID: 9727771
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary pulmonary hypertension. Treatment with prostacyclin I2 (epoprostenol)].
    Vicente R; Ramos F; Morales P
    Rev Esp Anestesiol Reanim; 1999; 46(6):274. PubMed ID: 10439652
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
    Gomberg-Maitland M; Preston IR
    Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Vasodilator Testing in Pulmonary Hypertension.
    Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
    Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandins in patients with pulmonary hypertension: the route of administration.
    Booke M; Van Aken H; Theilmeier G; Meyer J
    Anesth Analg; 1998 Apr; 86(4):917. PubMed ID: 9539630
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Delivery of inhaled aerosolized prostacyclin (IAP).
    van Heerden PV; Power BM; Leonard RC
    Anaesth Intensive Care; 1996 Oct; 24(5):624-5. PubMed ID: 8909691
    [No Abstract]   [Full Text] [Related]  

  • 27. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy.
    Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T
    J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epoprostenol for primary pulmonary hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):14-5. PubMed ID: 8592477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure.
    Schroeder RA; Wood GL; Plotkin JS; Kuo PC
    Anesth Analg; 2000 Aug; 91(2):291-5. PubMed ID: 10910834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in prostacyclin therapy for pulmonary arterial hypertension.
    Eells PL
    Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
    [No Abstract]   [Full Text] [Related]  

  • 31. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term prostacyclin reduces pulmonary vascular resistance in severe primary pulmonary hypertension.
    Barst RJ
    Clin Exp Rheumatol; 1998; 16(3):253-4. PubMed ID: 9631745
    [No Abstract]   [Full Text] [Related]  

  • 33. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
    Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
    J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging therapies for pulmonary hypertension: striving for efficacy and safety.
    Kao PN; Faul JL
    J Am Coll Cardiol; 2003 Jun; 41(12):2126-9. PubMed ID: 12821235
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
    Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
    J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.
    Lang IM; Gaine SP
    Eur Respir Rev; 2015 Dec; 24(138):630-41. PubMed ID: 26621977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
    Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
    Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
    [No Abstract]   [Full Text] [Related]  

  • 39. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    Botney M
    N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
    [No Abstract]   [Full Text] [Related]  

  • 40. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
    Jerath A; Srinivas C; Vegas A; Brister S
    Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.